Skip to main content

SLGL · Sol-Gel Technologies Ltd. · Holdings

Track SLGL — free
$67.50 -0.69 (-1.01%)
Market Cap
$214.45M
Shares
3.27M
Volume · Oct 28 23.87K Avg daily vol (3M) 54.62K

Institutional ownership from SEC Form 13F filings. Investment managers with more than $100 million in U.S. equities must disclose their positions every quarter, within 45 days of quarter-end, so the holdings shown can lag the market by up to a quarter.

The Sep 30, 2026 filing window is still open — showing the latest known positions. Funds that have not filed yet carry their prior-quarter positions; a fund that filed without this stock counts as sold out. Each fund's Change is measured against its own previous reported quarter, shown in the Reported column. Pick a completed quarter in the Quarter selector below to put every fund on one quarter and see the stock-wide activity breakdown.
Holders: 24
Total Value: $98,055,423
Total Shares: 1,322,554

Institutional Ownership Trend

27 quarters

Holder Concentration

Across 24 13F filers
Top Holder
37.8%
Sep 2023 → Jun 2026 · range 32.0% – 75.0%
of institutional value
Top 5
86.5%
Sep 2023 → Jun 2026 · range 86.5% – 99.9%
of institutional value
Top 10
96.4%
Sep 2023 → Jun 2026 · range 96.4% – 100.0%
of institutional value
HHI
2,158
Sep 2023 → Jun 2026 · range 2,158 – 5,989
Moderately concentrated

Who Holds SLGL

Last 8 quarters through Sep 30, 2026 (filing window open)

Each kind of 13F filer's share of the common shares 13F filers report. Holder type comes from regulatory records, never the filer's name; style, turnover and horizon are measured from each filer's own 13F book. The quarter selector does not change this card.

Jun 30, 2026, the newest closed quarter: 24 filers, like-for-like change +4.9%; actively managed books +5.0%; index-like books -9.2%.

Holder type Share Filers Change
Registered adviser 74.8% 9 +9.3%
Bank 0.0% 1 -57.1%
Broker-dealer 0.3% 1 +12.5%
Non-US 0.0% 1 0.0%
Holding company 0.4% 2 -9.2%
Unknown 24.5% 10 -6.3%

The Sep 30, 2026 filing window is still open, so its bar carries the Jun 30, 2026 positions of filers that have not filed yet.

How the mix is measured

Shares are 13F common shares restated to today's split basis; options and principal amounts are left out. The change compares only filers with a 13F in both quarters and keeps each filer in its bucket of the later quarter on both sides; a filer that continues under a new CIK is compared through its successor. Holder type comes from each filer's current regulatory profile; client base and private funds come from the Form ADV roster current at each quarter end (rosters from December 2019, so an earlier quarter reads Unknown). Style, turnover, horizon and book size are measured from each filer's 13F book in the newest measured quarter, and Not measured means none was. Actively managed books are those measured systematic-like, concentrated or diversified active.

Conviction and Crowding

24 13F filers, quarter ended Jun 30, 2026

Measured across every 13F filer's common-share book once the quarter's filing window closed. Crowding counts filers with high turnover or that advise private funds on Form ADV.

Conviction holders
2
8.33% of filers hold it in their top 10
Mar 31, 2026: 2
Holders above 5%
0
median weight 0.003%
Mar 31, 2026: 2
Crowding
—
a foreign private issuer reports ordinary shares, a different unit from the listed shares
Private-fund advisers
—
of shares outstanding
Institutional ownership
—
a foreign private issuer reports ordinary shares, a different unit from the listed shares
Top 10 holders
96.4%
of 13F shares, Herfindahl 0.216
Active holders
+5.0%
like-for-like share change of active filers
5% stakes on record
3
1 13D, 2 13G (0 institutional, 2 passive, 0 exempt)
How long holders have held it value-weighted 5.5 quarters
Under 1 year 50.2% 1 to 3 years 38.4% 3 years or more 11.4% Since coverage start 0.000%

Managers in the top fifth by current three-year FundScore alpha were net buyers of $0 (0 buying, 0 selling).

Estimated Holder Cost Basis

Quarter ended Jun 30, 2026, on that quarter's share basis

Estimated, never filed: each 13F buy is costed at its quarter's average traded price and each sale keeps the average cost, so this is what holders paid on average if they traded evenly through each quarter.

Estimated avg cost
$54.92
estimated per share
Mar 31, 2026: $52.16
Quarter-end price
$74.14
implied by 13F values
Estimated gain or loss
+35.0%
price against the estimated cost
Estimated at a loss
0.000%
of costed 13F value

Estimated cost covers 88.5% of the 13F shares; positions already held when a filer's 13F history starts, or bought in a quarter without a trusted average price, have no estimate.

Shared Holders

Companies SLGL's active holders also own, quarter ended Jun 30, 2026
# Company Shared holders
1 ELLO Ellomay Capital Ltd. 3
2 KTTA Pasithea Therapeutics Corp. 3
3 RZLT Rezolute, Inc. 4
4 IRD Opus Genetics, Inc. 4
5 PMN ProMIS Neurosciences Inc. 3
6 ICL ICL Group Ltd. 3
7 FBRX Forte Biosciences, Inc. 3
8 ENLT Enlight Renewable Energy Ltd. 3
9 ZNTL Zentalis Pharmaceuticals, Inc. 3
10 EPRX Eupraxia Pharmaceuticals Inc. 3

Shareholder Targets

13F filers that own its peers but not SLGL, quarter ended Jun 30, 2026

Found through its holder-overlap peers: ELLO, KTTA, RZLT, IRD, PMN, ICL, FBRX, ENLT, ZNTL, EPRX, TRAX, ANL, XFOR, IKT, OKUR, RLMD, MLTX, CAMT, GLBE, ELVN. 765 filers in all.

# Filer In peers
1 Clal Insurance Enterprises Holdings Ltd Unknown, Concentrated $1,429,052,156 4 held
2 VANGUARD CAPITAL MANAGEMENT LLC Registered adviser, Index-like $869,815,935 15 held
3 Harel Insurance Investments & Financial Services Ltd. Unknown, Diversified active $704,752,377 4 held
4 Y.D. More Investments Ltd Unknown, Concentrated $688,328,741 4 held
5 WASATCH ADVISORS LP Registered adviser, Diversified active $633,525,077 2 held
6 FMR LLC Holding company, Diversified active $632,637,730 15 held
7 Migdal Insurance & Financial Holdings Ltd. Holding company, Concentrated $601,657,788 3 held
8 Altshuler Shaham Ltd Unknown, Diversified active $470,121,783 4 held
9 PRICE T ROWE ASSOCIATES INC /MD/ Registered adviser, Diversified active $418,465,775 12 held
10 ORBIMED ADVISORS LLC Registered adviser, Diversified active $411,090,557 5 held
Showing 24 of 24
Export CSV
Holder Value (USD) % of 13F Shares Open
Key facts CIK 1684693 CUSIP M8694L137 13F (30d) 2 filings 2 filers Visit website Investor relations